<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005189A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005189</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14011110</doc-number><date>20130827</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><priority-claims><priority-claim sequence="01" kind="national"><country>FR</country><doc-number>0705789</doc-number><date>20070809</date></priority-claim><priority-claim sequence="02" kind="national"><country>FR</country><doc-number>0801819</doc-number><date>20080402</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>D</subclass><main-group>487</main-group><subgroup>04</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>D</subclass><main-group>487</main-group><subgroup>04</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>5142332</main-classification><further-classification>514248</further-classification><further-classification>544236</further-classification><further-classification>548163</further-classification></classification-national><invention-title id="d0e79">NOVEL 6-TRIAZOLOPYRIDAZINE SULFANYL BENZOTHIAZOLE DERIVATIVES AS MET INHIBITORS</invention-title><us-related-documents><division><relation><parent-doc><document-id><country>US</country><doc-number>12693736</doc-number><date>20100126</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8546393</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>14011110</doc-number></document-id></child-doc></relation></division><continuation><relation><parent-doc><document-id><country>US</country><doc-number>PCT/FR2008/001172</doc-number><date>20080806</date></document-id><parent-status>PENDING</parent-status></parent-doc><child-doc><document-id><country>US</country><doc-number>12693736</doc-number></document-id></child-doc></relation></continuation></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Albert</last-name><first-name>Eva</first-name><address><city>Paris</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Bacque</last-name><first-name>Eric</first-name><address><city>Paris</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Nemecek</last-name><first-name>Conception</first-name><address><city>Paris</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Ugolini</last-name><first-name>Antonio</first-name><address><city>Paris</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant><us-applicant sequence="04" app-type="applicant" designation="us-only"><addressbook><last-name>Wentzler</last-name><first-name>Sylvie</first-name><address><city>Paris</city><country>FR</country></address></addressbook><residence><country>FR</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Albert</last-name><first-name>Eva</first-name><address><city>Paris</city><country>FR</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Bacque</last-name><first-name>Eric</first-name><address><city>Paris</city><country>FR</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Nemecek</last-name><first-name>Conception</first-name><address><city>Paris</city><country>FR</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Ugolini</last-name><first-name>Antonio</first-name><address><city>Paris</city><country>FR</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Wentzler</last-name><first-name>Sylvie</first-name><address><city>Paris</city><country>FR</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>SANOFI</orgname><role>03</role><address><city>Paris</city><country>FR</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The disclosure relates to compounds of formula (I):</p><p id="p-0002" num="0000"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="26.25mm" wi="63.08mm" file="US20140005189A1-20140102-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif"/></chemistry></p><p id="p-0003" num="0000">wherein <img id="CUSTOM-CHARACTER-00001" he="3.56mm" wi="4.57mm" file="US20140005189A1-20140102-P00001.TIF" alt="custom-character" img-content="character" img-format="tif"/>, A, W, X, and Ra are as defined in the disclosure, and salts thereof, and to pharmaceutical compositions comprising said compounds, to processes for preparing them, and to their use as medicaments, in particular as MET inhibitors.</p></abstract></us-patent-application>